KUY-19034-74076
3 vaccinations
5 coded responses
35 check-ins
5 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 280 / NC
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Moderna
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-01
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-02
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-03
- 2021-01-04
-
2021-01-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-01-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-06
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-07
- 2021-01-14
-
2021-01-21
Survey response — day 21, dose 1MedDRA: Eye pruritus, Lacrimation increased, Rhinorrhoea, Sneezing — Feeling: GoodFree text: Sneezing, itchy watery eyes, runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-28
Dose 2 — Moderna
-
2021-01-29
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea — Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-30
- 2021-01-31
- 2021-02-03
- 2021-02-06
- 2021-02-11
- 2021-02-18
- 2021-02-26
- 2021-03-04
- 2021-03-13
- 2021-04-30
- 2021-07-31
-
2021-11-01
Dose 3 — Moderna
-
2021-11-01
Survey response — day 0, dose 3MedDRA: Asthma, Pre-existing disease — Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Asthma exacerbationMedDRA releases: 2024-11 · check-in free text available
-
2021-11-02
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-11-03
- 2021-11-04
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-17
- 2021-11-22
- 2021-11-29
- 2021-12-06
-
2022-01-31
Survey response — 3 months, dose 3MedDRA: Abortion spontaneous, COVID-19, Cough, Headache, Nasal congestion, Oropharyngeal pain, Pain, Pyrexia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever, headache, body aches, nasal congestion, cough, sore throat stemming from positive Covid on 01/29/22. Had a miscarriage on 01/07/22MedDRA releases: 2024-11 · check-in free text available
-
2022-05-02
Survey response — 6 months, dose 3MedDRA: Abortion spontaneous — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Missed miscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-05-02
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-03
-
2022-05-03
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-11-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Moderna | |
| 2 | 2021-01-28 | Moderna | |
| 3 | 2021-11-01 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-01 | priority 2/3 | |
| 2021-01-06 | priority 2/3 | |
| 2022-05-02 | Successful 2022-05-03 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 2 — day 21, dose 1
Symptoms: Sneezing, itchy watery eyes, runny nose
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Shortness of breath
Release 10 — day 0, dose 3
Systemic reaction (other): Asthma exacerbation
Release 11 — 3 months, dose 3
Symptoms: Fever, headache, body aches, nasal congestion, cough, sore throat stemming from positive Covid on 01/29/22. Had a miscarriage on 01/07/22
Release 11 — 6 months, dose 3
Symptoms: Missed miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Eye pruritus | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Lacrimation increased | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
| SRO | Asthma | · | · | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release